Revolution Medicines

Price & Volume

Stats

52W Range	$29.17-$124.49
Market Cap	$18.6B
Shares Short	13M

Financials

Revenue (12 Mos)	$742,000
Revenue Growth (YoY)	-95.2%
Gross Profit (12 Mos)	-$880.4M
Diluted EPS	-$5.19

News

Yahoo Finance • 2 months ago

All J.P. Morgan's top stock picks for 2026

Yahoo Finance • 2 months ago

Here are the most and least likely M&A targets in biotech, according to Truist

Yahoo Finance • 2 months ago

Revolution Medicines Announces First Patient Randomized in the RASolute 304 Clinical Trial of Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma Following Adjuvant Chemotherapy

Yahoo Finance • 3 months ago

Revolution Medicines outlines multiple Phase III trial launches and commercial buildout amid increased R&D investment

About

CEO	Dr. Mark A. Goldsmith M.D., Ph.D.
Address	700 Saginaw Drive, Redwood City, CA, United States, 94063
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	809